User interface language: English | Español

Date May 2011 Marks available 3 Reference code 11M.3.SL.TZ2.17
Level Standard level Paper Paper 3 Time zone Time zone 2
Command term Describe Question number 17 Adapted from N/A

Question

Describe the use of viral vectors in gene therapy.

Markscheme

gene therapy involves replacing defective genes;
desired gene is inserted into the viral genome;
viruses can be modified to infect only target cells and not self-replicate / modified for safe use;
somatic cells are removed (for receiving the new genes);
the desired gene is introduced into the target/somatic cells;
altered cells are returned to the patient for expression of the gene;
properly described verified example e.g. replacement of gene for production of ADA in SCID / introduction of gene/RPE65 (in retina) to restore vision in inherited blindness (LCA) / replacement of factor IX/blood clotting factor gene in hemophilic patients;

Examiners report

N/A

Syllabus sections

Option B: Biotechnology and bioinformatics » Option B: Biotechnology and bioinformatics (Additional higher level topics) » B.4 Medicine
Show 36 related questions

View options